diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM2013433-37diaendo-3870Research ArticleВопросы патогенезаPathogenesisАнализ фосфорно-кальциевого обмена и функции паращитовидных желез у больных сахарным диабетом 1 типаAnalysis of the calcium-phosphorus metabolism and function of the parathyroid glands in patients with type 1 diabetes mellitusХантаковаЕкатерина АлександровнаKhantakovaEkaterina Alexandrovna

ассистент кафедры эндокринологии и клинической фармакологии

assistant of the Endocrinology and Clinical Pharmacology department

hantakovaea@mail.ruХамнуеваЛариса ЮрьевнаKhamnuevaLarisa Yur'evna

доктор медицинских наук, профессор, заведующая кафедрой эндокринологии и клинической фармакологии

MD, PhD, Professor, Head of the Endocrinology and Clinical Pharmacology department

hantakovaea@mail.ruОрловаГалина МихайловнаOrlovaGalina Mikhailovna

доктор медицинских наук, профессор, заведующая кафедрой госпитальной терапии

MD, PhD, Professor, Head of the Hospital therapy department

hantakovaea@mail.ruГБОУ ВПО Иркутский государственный медицинский университет, ИркутскРоссияIrkutsk state medical UniversityRussian Federation2013181220131643337Copyright © Хантакова Е.А., Хамнуева Л.Ю., Орлова Г.М., 20132013Хантакова Е.А., Хамнуева Л.Ю., Орлова Г.М.Khantakova E.A., Khamnueva L.Y., Orlova G.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/3870сахарный диабет 1 типадиабетическая нефропатиякальцийфосфорпаратиреоидный гормонгликемияtype 1 diabetesdiabetic nephropathycalciumphosphorusparathyroid hormoneblood glucoseReferencesLevin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71(1):31–38.Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71(1):31–38.doi: 20.1038/sj.ki.5002009.doi: 20.1038/sj.ki.5002009.Смирнов АВ, Волков ММ, Галкина ОВ, Жлоба АА, Эмануэль ВЛ. Взаимосвязь уровней витамина D, паратгормона, кальция, фосфатов крови у пациентов с хронической болезнью почек, не получающих терапию, замещающую функцию почек. Терапевтический архив. 2009;81(8):49–52. [Correlations between the levels of vitamin D, parathormone, calcium, blood phosphates in patients with chronic disease of the kidneys untreated with replacement renal therapy.Terapevticheskii arkhiv.2009;(8):49–52.]Смирнов АВ, Волков ММ, Галкина ОВ, Жлоба АА, Эмануэль ВЛ. Взаимосвязь уровней витамина D, паратгормона, кальция, фосфатов крови у пациентов с хронической болезнью почек, не получающих терапию, замещающую функцию почек. Терапевтический архив. 2009;81(8):49–52. [Correlations between the levels of vitamin D, parathormone, calcium, blood phosphates in patients with chronic disease of the kidneys untreated with replacement renal therapy.Terapevticheskii arkhiv.2009;(8):49–52.]Wahl P, Xie H, Scialla J, Anderson CA, Bellovich K, Brecklin C, et al, Group CRICS. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care 2012;35(5):994–1001.Wahl P, Xie H, Scialla J, Anderson CA, Bellovich K, Brecklin C, et al, Group CRICS. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care 2012;35(5):994–1001.doi: 10.2337/dc11-2235doi: 10.2337/dc11-2235Murakami R, Murakami S, Tsushima R, Ueda C, Mikami K, Ebina T, et al. Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy. Nephrol Dial Transplant 2007;23(1):315–320.Murakami R, Murakami S, Tsushima R, Ueda C, Mikami K, Ebina T, et al. Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy. Nephrol Dial Transplant 2007;23(1):315–320.doi: 10.1093/ndt/gfm639doi: 10.1093/ndt/gfm639Yamamoto T, Ozono K, Miyauchi A, Kasayama S, Kojima Y, Shima M, et al. Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. Am. J. Kidney Dis 2001;38(4 Suppl 1):161. PubMed PMID: 11576945.Yamamoto T, Ozono K, Miyauchi A, Kasayama S, Kojima Y, Shima M, et al. Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. Am. J. Kidney Dis 2001;38(4 Suppl 1):161. PubMed PMID: 11576945.Campos Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano Pardo MD, Garcia – Cervigon AG. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporosis International 2000;2000(11):455.Campos Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano Pardo MD, Garcia – Cervigon AG. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporosis International 2000;2000(11):455.Martinez I. Moina I, Montenegro J, Saracho R, Llach F. Is there a lesser hyperparathyroidism in diabetic patients with chronic renal failure. Nephrology Dialysis Transplantation 1998;13(Suppl 3):9–11.Martinez I. Moina I, Montenegro J, Saracho R, Llach F. Is there a lesser hyperparathyroidism in diabetic patients with chronic renal failure. Nephrology Dialysis Transplantation 1998;13(Suppl 3):9–11.doi: 10.1093/ndt/13.suppl_3.9doi: 10.1093/ndt/13.suppl_3.9K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):1–266.K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):1–266.Tomasello S. Secondary Hyperparathyroidism and Chronic Kidney Disease. Diabetes Spectrum. 2008;21(1):19–25.Tomasello S. Secondary Hyperparathyroidism and Chronic Kidney Disease. Diabetes Spectrum. 2008;21(1):19–25.doi: 10.2337/diaspect.21.1.19doi: 10.2337/diaspect.21.1.19Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int. 1990;37(6):1522–1527.Sugimoto T, Ritter C, Morrissey J, Hayes C, Slatopolsky E. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int. 1990;37(6):1522–1527.doi: 10.1038/ki.1990.144doi: 10.1038/ki.1990.144Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. Clin J Am Soc Nephrol. 2007;18(3):896–903.Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. Clin J Am Soc Nephrol. 2007;18(3):896–903.Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 2007;30(5):1049–1055.Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 2007;30(5):1049–1055.doi: 10.2337/dc06-2127doi: 10.2337/dc06-2127

The authors declare that there are no conflicts of interest present.